Herceptin (trastuzumab) is a targeted therapy for HER2-positive breast cancer, and while it’s effective, there are specific medications, vaccines, and lifestyle factors you should steer clear of during treatment. The biggest concern is your heart. Herceptin can weaken heart function on its own, and certain combinations make that risk significantly worse.
Anthracycline Chemotherapy Drugs
The single most important drug interaction to know about is between Herceptin and a class of chemotherapy drugs called anthracyclines. The FDA’s prescribing label carries its strongest warning about this combination: the incidence and severity of heart failure is highest when Herceptin is given alongside anthracycline-containing regimens. The combination can cause serious cardiac dysfunction, including heart failure and, in rare cases, cardiac death.
What makes this interaction especially important is that the risk doesn’t end when you stop Herceptin. The drug lingers in your body for months after your last infusion, so even receiving an anthracycline after finishing Herceptin can be dangerous. The FDA recommends avoiding anthracycline-based therapy for up to 7 months after stopping Herceptin. If your oncology team determines an anthracycline is necessary despite this, your heart function should be monitored closely throughout.
Why Heart Health Matters on Herceptin
Even without anthracyclines in the picture, Herceptin can affect how well your heart pumps. Your care team will measure something called your ejection fraction, which is essentially the percentage of blood your heart pushes out with each beat. A healthy heart typically ejects 55% or more. A drop of 10 percentage points or more to below 53% is considered significant enough to potentially pause or stop treatment, and this happened in about two-thirds of patients who developed heart problems during therapy in clinical studies.
You’ll have heart scans at baseline, then every 3 months throughout treatment, and every 6 months for at least 2 years after you finish. This schedule exists because heart problems can develop at any point, not just early on. If you notice new shortness of breath, swelling in your legs or ankles, a persistent cough, or unusual fatigue, bring it up with your care team right away rather than waiting for your next scheduled scan.
Live Vaccines to Avoid
Herceptin suppresses parts of your immune system, which means live vaccines (those containing weakened but active virus) can pose a real infection risk. The following live vaccines should not be given during treatment:
- MMR (measles, mumps, rubella)
- Chickenpox (varicella)
- Yellow fever
- Typhoid (oral form)
- BCG (tuberculosis)
- Smallpox/monkeypox
- Dengue
Several other live vaccines, including the nasal spray flu vaccine and oral rotavirus vaccine, are usually not recommended but may be considered in specific situations. Inactivated vaccines (like the standard flu shot or COVID vaccines) are generally fine. If you need any vaccination during treatment, let the provider know you’re on Herceptin so they can check whether a non-live alternative exists.
Sun Exposure With Certain Combinations
Herceptin alone isn’t known to cause significant sun sensitivity. However, if you’re receiving it alongside paclitaxel (a common combination for HER2-positive breast cancer), the pairing can trigger photosensitive skin reactions. In documented cases, patients developed rashes tied to disruptions in how the body processes certain light-sensitive compounds. The rashes resolved once the triggering drug was stopped and sun exposure was reduced. If you’re on this combination, protecting your skin with high-SPF sunscreen, hats, and shade is a practical precaution, particularly during peak UV hours.
Pregnancy During and After Treatment
Herceptin can harm a developing fetus, and the FDA labels it with a warning about use during pregnancy. Because the drug stays in your system well beyond your last infusion (the same long washout period that affects the anthracycline interaction), effective contraception is essential throughout treatment and for at least 7 months after your final dose. If you’re planning a pregnancy after completing Herceptin, discuss timing with your oncologist to ensure the drug has fully cleared your system.
Alcohol and Supplements
There’s no strong clinical evidence that moderate alcohol use directly interacts with Herceptin at a drug level. That said, alcohol is an independent stressor on your heart, and since Herceptin already puts cardiac function at risk, minimizing alcohol is a reasonable approach during treatment. Heavy drinking in particular adds unnecessary strain to a heart that’s already being monitored for potential weakening.
For herbal supplements, no specific interactions with Herceptin have been well-documented in major guidelines. But many herbal products can interfere with other chemotherapy drugs you may be receiving alongside Herceptin, or they may have immune-modulating effects that complicate treatment. Bring a full list of everything you take, including over-the-counter supplements, to your oncology appointments so your team can flag anything that might be problematic with your specific regimen.
Infusion Day Precautions
Herceptin is given intravenously, and the first infusion carries the highest risk of an infusion reaction. Symptoms like chills, fever, low blood pressure, and difficulty breathing can develop during or shortly after the drip. For this reason, you’ll typically be observed for about 6 hours after your first dose. Subsequent infusions tend to be shorter with less monitoring, but reactions can still occur at any point during treatment. Let your infusion nurse know immediately if you feel feverish, shaky, or short of breath during any session.